Meet development partner Skyepharma at inaugural Connect-in Pharma event in Geneva

Saint-Quentin-Fallavier, France: -As a leading European fully-formed contract development and manufacturing organisation (CDMO), French-based Skyepharma Productions S.A.S. (Skyepharma) will be a prominent presence at the inaugural Connect-In Pharma networking conference and exhibition in Geneva.

Dedicated to the value chain downstream from the molecule and biotechnology, Connect in Pharma aims to drive innovation, business and new partnerships in four key areas: Innovative packaging, drug delivery systems, CMO/CDMO, and filling & assembling processes

Drug delivery solutions

Skyepharma will be there to promote its added-value solutions in terms of CDMO & drug delivery. It will be among the 90 exhibitors, with a stand at Booth D28 at the Geneva PalExpo.

The Skyepharma team in Geneva will include Chief Commercial Officer Laurent Rigaudeau, Pharmaceutical Development Director Aline Moulin, Senior Business Development Manager, Vincent Pasquier, and Project Manager Marion Quaillet.

HPAPI Capabilities 

“We are excited to be at the inaugural edition of this dynamic event,” commented M. Rigaudeau.

“Amongst other aims, we want to take the opportunity of this conference to promote the extension of our capabilities in the highly-potent HPAPI active ingredients area, both for development and manufacturing,” he explained.

About Skyepharma Production

Skyepharma is an independent French pharmaceutical CDMO, 100% owned by its management team and Bpifrance. Skyepharma is an expert CDMO specialised in the formulation, development and manufacturing of complex oral solid forms (OSD), with a specific expertise and proprietary technologies on modified release products.

Skyepharma is based in Saint-Quentin-Fallavier, France. The current factory, dedicated to its OSD activity, occupies 22,000m², on a 60,000m² piece of land. Skyepharma has decided to allocate a portion of the available land (more than 20,000m²) to establish its SkyeHub Bioproduction, an innovative model designed to offer clinical and commercial production capacities to biotech companies. This SkyeHub model includes the construction of dedicated buildings, with specifically designed surfaces and premises, together with transverse support services such as quality, maintenance, batch release, etc.

Learn more at: www.skyepharma.fr

About Connect-In Pharma 2020

Connect-in Pharma is a pioneering annual event focusing on core pharmaceutical packaging and drug delivery innovations, intended as a market tool to reach the epicenter of the pharma and biopharma industry.

Connect-in Pharma brings together suppliers, associations, clusters and world-leading companies in pharmaceutical and biotechnological production.

The inaugural conference will be a two day event opening September 14 at the PalExpo in Geneva, at the heart of the European pharmaceutical industry.

The program is intended to the paradigm of global pharmaceutical collaboration by developing a new life science ecosystem that supports pioneers in the pharma and biopharma industry.

Dedicated on the value chain downstream from the molecule and biotechnology, Connect in Pharma will drive innovation, business and new partnerships, featuring more than 90 exhibitors from the key areas of innovative packaging, drug delivery systems, CMO/CDMO, and filling & assembling processes.

The event is organized by Connect 365 with further details at: https://www.connectinpharma.com

Resources

Click on Meet Skyepharma to connect with the latest events.